Quick Links

 Selected Publications

Nowicki MJ, Vigen C, Mack WJ, Seaberg E, Landay AL, Greenblatt R, Anastos K, Cohen M, Minkoff H, Levine AM:  Association of cells with natural killer and NKT immunophenotype with incident cancers in HIV infected women.  AIDS Res and Human Retroviruses 2008; 24:163-8.

Khalsa A, Karim R, Mack WJ, Minkoff H, Cohen M, Young M, Anastos K, Tien PC, Seaberg E, Levine AM:  Correlates of prevalent hypertension in a large cohort of HIV-infected women: Women’s Interagency HIV Study (WIHS).  AIDS 2007; 21:2539-41.

Nowicki MJ, Karim R, Mack W, Levine AM:  Correlates of CD4/CD8 Count in HIV-Negative Women of WIHS Cohort.  Human Immunology.  In press.  2007.

Lim ST, Fayad L, Tulpule A, Modiano M, Espina BM, Cabanillas F, Laffranchi B, Allievi C, Bernareggi A, Levine AM:  A Phase I/II Trial of Pixantrone (BBR2778), Methylprednisolone, Cisplatin, and Cytosine Arabinoside (PSHAP) in Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL). Leukemia and Lymphoma 2007; 48:374-80.

Levine AM:  Hodgkin lymphoma:  To the HAART of the Matter (Editorial).  Blood 2006; 108:3630-31.

Levine AM:  Monoclonal gammopathy associated with HIV infection: Commentary.  Clin Infect Disease 2006; 43:1206-8.

Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA:  Progressive prothrombotic state in women with advancing HIV disease.  JAIDS 2006; 42:572-7.

Shaye OS and Levine AM:  Marginal Zone Lymphoma. Jour NCCN 2006; 4:311-318.

Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Espina BM, Groshen SG, Masood R, Gill PS: Phase I study of anti-sense oligonucleotide against vascular endothelial growth factor (VEGF-AS): Decrease in plasma VEGF with potential clinical efficacy. J Clin Oncol 2006; 24: 1712-1719.

Levine AM, Karim R, Mack W, Gravink DJ, Anastos K, Young M, Cohen M, Newman M, Augenbraun M, Gange S, Watts DH: Neutropenia in HIV infection: Data from the Women’s Interagency HIV Study. Archives Internal Medicine, 2006; 166:405-410.

Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM: Prognostic factors in HIV related diffuse large cell lymphoma: Before versus after highly active antiretroviral therapy. J Clin Oncol 2005; 23: 8477-8482.

Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM: AIDS-Related Burkitt’s Lymphoma (HIV-BL) versus Diffuse Large cell Lymphoma (HIV-DLCL) in the Pre-HAART and HAART Eras: Significant Differences in Survival with Standard Chemotherapy. JCO 23:4430-4438, 2005.

Richardson JL, Mowicki M, Danley K, Martin EM, Cohen MH, Gonzalez R, Vassileva J, Levine AM: Neuropsychological functioning in a cohort of HIV and HCV infected women. AIDS 2005; 19(15):1659-1667.

Lim ST, Levine AM: Angiogenesis and Hematological Malignancies. Hematology 10:11-24, 2005.

Lim ST, Rubin N, Said J, Levine AM: Primary Effusion Lymphoma (PEL): Successful treatment with highly active antiretroviral therapy (HAART) and Rituximab. Ann Hematol 84:551-552, 2005.

Lim ST, Tupule A, Espina BM, Levine AM: Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 103:417-21, 2005.

Saag MS, Bowers P, Leitz GJ, Levine AM: Once weekly epoeitin alfa improves quality of life and increases hemoglobin in anemic HIV infected patients. AIDS Res Hum Retroviruses 20:1037-1045, 2004.

Levine AM, Tulpule A, Espina B, Sherrod A, Boswell WD, Lieberman RD, Nathwani BN, Welles L: Liposome encapsulated doxorubicin (Myocet) in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS related non-Hodgkin’s lymphoma: Results of therapy and correlates of response. J Clin Oncol 22:2662-2670, 2004.

Arzoo KK, Bu X, Espina BM, Seneviratne L, Nathwani B, Levine AM: T cell lymphoma in HIV infected patients. JAIDS 36:1020-1027, 2004.

Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM: Impact of highly active anti-retroviral therapy on anemia, and relationship between anemia and survival in a large cohort of HIV infected women: Women’s Interagency HIV Study. JAIDS 37:1245-1252, 2004.

Hessol NA, Seaberg EC, Preston-Martin S, Massad LS, Sacks HS, Silver S, Melnick S, Abulafia D, Levine AM: Cancer risk among participants in the Women’s Interagency HIV Study (WIHS). JAIDS 36:978-985, 2004.

Machida K, Cheng KTN, Sung VMH, Shimodaira S, Lindsay KL, Levine AM, Lai M-Y, Lai MMC: Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protoooncogenes. Proc Nat Acad Sci, USA 101:4262-4267, 2004.

Tulpule A, Espina BM, Santabarbara ABP, Palmer M, Schiflett J, Boswell W, Smith S, Levine AM: Treatment of AIDS related non-Hodgkin’s lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: Results of a Phase II study. Investigational New Drugs 22:63-68, 2004.

Levine AM, Shimodaira S, Lai MMC: Treatment of HCV related mantle cell lymphoma with ribavirin and pegylated interferon alfa. N Engl J Med 349:2078-79, 2003.

Stripecke R, Koya RC, Ta HQ, Kasahara N, Levine AM: The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors. Blood Cells, Molecules and Diseases 31:28-37, 2003.

Levine AM: Challenges in the management of Burkitt's lymphoma. Clinical Lymphoma 3:S19-25, 2002.

Levine AM: Evaluation and management of the HIV infected woman: Review. Annals Intern Med 136:228-242, 2002.

Preston-Martin S, Kirstein L, Pagoda JM, Melnick SL, Masri-Lavine L, Silver S, Hessol N, French AL, Feldman J, Sacks HS, Rimer B, Deely M, Levine AM: Use of mammographic screening by HIV infected women in the Women’s Interagency HIV Study. Preventive Medicine 34:386-392, 2002.

Levine AM, Sadeghi S, Espina B, Tulpule A, Nathwani B: Characteristics of indolent non-Hodgkin’s lymphoma in patients with type 1 Human Immunodeficiency Virus infection. Cancer 94:1500-1506, 2002.

Tulpule A, Sherrod A, Dharmapala D, Young LL, Espina BM, Sanchez MN, Gill PS, Levine AM: Multidrug resistance (MDR-1) expression in AIDS related lymphomas. Leukemia Research 26:121-127, 2002.

Seneviratne L, Tulpule A, Espina BM, Chen JA, Nathwani B, Levine AM: Clinical, immunologic and pathologic correlates of bone marrow involvement in 291 patients with AIDS-related lymphoma. Blood 98:2358-2363, 2001.

Bi J, Espina BM, Tulpule A, Boswell W, Levine AM: High dose cytosine arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS related non-Hodgkin’s lymphoma. J AIDS 28:416-421, 2001.

Nelson RA, Levine AM, Bernstein L: Reproductive factors and risk of intermediate or high grade B cell non-Hodgkin’s lymphoma in women. J Clin Oncol 19:1381-1387, 2001.

Levine AM, Berhane K, Masri-Lavine L, Sanchez ML, Young M, Augenbraun M, Cohen MN, Anastos K, Newman M, Gange SJ, Watts H: Prevalence and correlates of anemia in a large cohort of HIV infected women: Women’s Interagency HIV Study. JAIDS 26:28-35, 2001.

Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS: Evolving characteristics of AIDS related lympomas. Blood 96:4084-4090, 2000.

Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN, Ratner L: ABVD chemotherapy with G-CSF in HIV infected patients with newly diagnosed Hodgkin’s Disease: A prospective, multi-institutional AIDS Clinical Trials Group Study (ACTG # 149). J AIDS 24:444-450, 2000.

This is a partial list. Full publications list available upon request. Information on this page may be self-reported and is subject to change at any time. Last updated: 07/08.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.